A two-pronged approach to regulate the behaviors of ECs and SMCs by the dual targeting-nanoparticles-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A two-pronged approach to regulate the behaviors of ECs and SMCs by the dual targeting-nanoparticles

Published:2021-12 Issue: Volume:208 Page:112068
ISSN:0927-7765
Container-title:Colloids and Surfaces B: Biointerfaces
language:en
Short-container-title:Colloids and Surfaces B: Biointerfaces

Author:

Wang Xiaoyu,Gao Bin,Ren Xiang-kui,Guo Jintang,Xia Shihai,Zhang Wencheng,Yang Cheng,Feng Yakai

Publisher

Elsevier BV

Subject

Colloid and Surface Chemistry,Physical and Theoretical Chemistry,Surfaces and Interfaces,General Medicine,Biotechnology

Reference30 articles.

1. Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study;Dagenais;Lancet,2020

2. Nanoparticle drug- and gene-eluting stents for the prevention and treatment of coronary restenosis;Yin;Theranostics,2014

3. A pH/ROS dual-responsive and targeting nanotherapy for vascular inflammatory diseases;Zhang;Biomaterials,2020

4. Smooth muscle cell-targeted RNA aptamer inhibits neointimal formation;Thiel;Mol. Ther.,2016

5. Target regulation of both VECs and VSMCs by dual-loading miRNA-126 and miRNA-145 in the bilayered electrospun membrane for small-diameter vascular regeneration;Cui;J. Biomed. Mater. Res., Part A,2019

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A dual gene combination therapy approach by KRAS-G12V gene editing and SLC25A22 gene silencing for KRAS-mutant colorectal cancer;Nano Today;2024-06

2. The interaction between particles and vascular endothelium in blood flow;Advanced Drug Delivery Reviews;2024-04

3. Chitosan Hydrogel as Tissue Engineering Scaffolds for Vascular Regeneration Applications;Gels;2023-05-01

4. Partially Reduced MIL-100(Fe) as a CO Carrier for Sustained CO Release and Regulation of Macrophage Phenotypic Polarization;ACS Biomaterials Science & Engineering;2022-10-18

5. Non-viral nucleic acid therapeutics: Revolutionizing the landscape of atherosclerotic treatment;Nano Today;2022-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3